The biotech company's shares surged after announcing an ambitious plan for its sublingual drug delivery technology and boosting its 2026 financial outlook.
The non-dilutive capital is aimed at advancing the company's battery manufacturing capabilities and bolstering its position in the U.S. supply chain.
Autonomous trucking firm's shares rose 2.2% in after-hours trading after the billionaire's fund disclosed a 5.7% passive investment.
A multibillion-dollar AI agreement is in limbo as the US Commerce Department scrutinizes the UAE's ties to Beijing, potentially impacting Nvidia's growth.
The recently-listed Hong Kong construction firm's shares plummeted to all-time lows, triggering multiple volatility halts amid a lack of news.
The battery manufacturer secured a key grant to modernize its production facilities and expand workforce development programs.
The strategic move strengthens the AI firm's balance sheet as it accelerates its Web 3.0 data monetization and supercomputing initiatives.
The move pressures credit bureaus, with competitors TransUnion and Equifax seeing their stock prices fall sharply in response.